EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Recent Advances in the Development of Hybrid Drugs

Tânia S Morais iD

Pharmaceutics · 01.07.2024 · 16 (7) · 889

DOI: 10.3390/pharmaceutics16070889 ↗

Kurz gefasst

Editorial in der Zeitschrift Pharmaceutics, online erschienen am 01.07.2024. Verfasst von Tânia S Morais. Beteiligte Einrichtung: Centro de Química Estrutural, Institute of Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia (FCT), FCT POPH and FSE-European Social Funds.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the search for innovative, selective, effective, and safer treatment strategies, hybrid drugs have gained worldwide momentum [...]

Autor:innen und Institutionen

  • Centro de Química Estrutural, Institute of Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal.
  • Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal.

ORCID-Profile: Tânia S Morais

Förderung

  • Fundação para a Ciência e Tecnologia (FCT)
  • FCT POPH and FSE-European Social Funds

Zitieren

APA

Morais, T. S. (2024). Recent Advances in the Development of Hybrid Drugs. Pharmaceutics, 16(7), 889. https://doi.org/10.3390/pharmaceutics16070889

Vancouver

Morais TS. Recent Advances in the Development of Hybrid Drugs. Pharmaceutics. 2024;16(7):889. doi:10.3390/pharmaceutics16070889

BibTeX
@article{Morais2024,
  author = {Morais, Tânia S},
  title = {Recent Advances in the Development of Hybrid Drugs},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {7},
  pages = {889},
  doi = {10.3390/pharmaceutics16070889}
}
Kostenlos starten →